Marketing agreement inked

Nov. 29, 2006
Carrington enters into a representative agreement for dental market with Executive Sales Associates.

IRVING, Texas--Carrington Laboratories, Inc. has announced it has entered into a three-year representative agreement with Executive Sales Associates for Carrington's SaliCept professional line of oral patches and rinses. 

The patches are used for the management of dry socket, general lesions or irritations in the oral cavity and canker sores. The rinse is used to manage problems associated with stomatitis and mucositis caused by radiation or chemotherapy. Both the SaliCept patch and rinse relieve pain.

Under the terms of the agreement, Carrington will supply ESA with the SaliCept line of products for use in the management of dry socket for distribution into the dental practitioner market. 

In return, ESA will be responsible for the sales, marketing and distribution of these products through their diversified network of national and regional dental distributors and supported by their North American sales force of twenty-three professional sales people.

"This is a great opportunity to drive additional revenues in a fast growing segment, further diversify the markets that Carrington serves and increase the brand awareness of the SaliCept line and its benefits to dental practitioners and their patients, said Doug Golwas, Carrington's vice president of Corporate Sales and Marketing. 

"ESA has a proven track record of taking quality products and delivering steady, long term growth through its sales force in the United States and Canada. They also have high level relationships with the key channels in the dental space."

The SaliCept line of oral patches and rinses fits within ESA's direction of providing the highest quality products to dental practitioners for the care of their patients. 

SaliCept patches are produced at Carrington's facilities in Costa Rica and the rinse at Carrington facilities in Texas. Both facilities are ISO certified and produce products under current good manufacturing practices as recognized by the FDA; thus, meet or exceed ESA quality demands. 

Additionally, both products carry the CE mark required for sale and marketing in the European Union.